This inventor holds 14 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: The United States of America as Represented by the Department of Health, Purdue Research Foundation, The University of Alabama. Active years: 1986-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bethesda, IN (US) (1993)
- Bethesda, MD (US) (1986 - 2002)
Company Filing History:
6 out of 1,217 
4 out of 2,793 
2 out of 330 
Years Active: 1986-2002
Areas of Expertise:
Title: A Spotlight on Inventor Rudiger D Haugwitz
Introduction
Rudiger D Haugwitz, based in Bethesda, MD, is a notable inventor recognized for his significant contributions to pharmaceutical chemistry. With an impressive portfolio of 14 patents, Haugwitz has been at the forefront of innovations targeting critical health issues, particularly in the realm of cancer therapy and antiviral treatments.
Latest Patents
Among his latest patents are derivatives of Brefeldin A, which are cytotoxic Michael addition derivatives. These compounds exhibit enhanced cytotoxic activity compared to their sulfides and sulfones, particularly against a variety of human cancer cell lines. His research details the process of oxidizing thiol addition products of Brefeldin A to produce corresponding sulfoxides and sulfones, paving the way for pharmaceutical formulations that could be pivotal in cancer treatment. Additionally, Haugwitz has developed Aroylaniline compounds that demonstrate anti-retroviral activity. These compounds, along with their pharmaceutical compositions, present methods for effectively treating hosts infected with retroviruses.
Career Highlights
Throughout his career, Rudiger D Haugwitz has worked with reputable organizations, contributing his expertise in pharmaceutical research. He has served with the United States of America as represented by the Department of Health and has collaborated with the Purdue Research Foundation. His endeavors in these institutions underscore his commitment to advancing medical science.
Collaborations
Haugwitz has collaborated with esteemed colleagues, including Venkatachala L Narayanan and Leon H Zalkow, enhancing the collaborative spirit in his research environment and fostering innovative solutions to complex health challenges. These partnerships have been instrumental in propelling forward the development of transformative pharmaceuticals.
Conclusion
Rudiger D Haugwitz stands as a figure of inspiration in the field of pharmaceutical innovation. With his 14 patents and a focus on developing effective treatments for cancer and retroviral infections, he continues to contribute significantly to the advancement of medical technology. His work demonstrates the profound impact that dedicated inventors can have on public health and the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile